Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

2590 PWToday Stories

Universal Health Services, Inc. Completes the Acquisition of Cambian Group PLC's Adult Services Division

29 Dec 16

Universal Health Services, Inc. announced today that it has completed the previously announced acquisition of Cambian Group, PLC's Adult Services Division, which will significantly expand the company's market presence in the United Kingdom.

As announced previously, UHS agreed to purchase the adult services division of Cambian Group, PLC for a total purchase price of £377 million (or approximately $464 million). For 2016, the Cambian Adult Services Division is expected to produce revenue of approximately £142 million (or $175 million) and adjusted EBITDA of approximately £35 million (of $43 million). The acquisition of the Cambian Adult Services Group adds 81 behavioral facilities with 1,193 beds to the Cygnet family in the U.K. This diverse group of facilities provides care to adults with mental health disorders, intellectual disabilities, autism, personality disorders and acquired brain conditions.  With the addition of the Cambian Adult Services Division, UHS will have a total of 102 facilities with approximately 2,250 beds in the U.K.

"We are pleased to close this strategic acquisition, which positions UHS for continued future growth in a market that is increasingly important to the company," said Alan B. Miller, CEO and Chairman of the Board of UHS. "The Cambian Group has an excellent reputation as a quality provider and brings expertise in services geared to adults and children with a variety of mental health needs. Importantly, they share UHS's 'patients first' philosophy and our commitment to clinical quality. They have excellent Care Quality Commission scores, an important and recognized measure in the UK, as well as patient outcomes. Working together with Cygnet, our existing business in the UK, the acquisition of these Cambian facilities will ensure that we are well positioned to serve patients, customers and communities with a broad range of innovative treatment services and products."  

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.